MIRM — Mirum Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Mirum Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	232	157	152	286	280
Net Total Accounts Receivable
Net Total Receivables	—	3.27	24	68	78.3
Total Inventory
Prepaid Expenses
Total Current Assets	236	167	190	388	393
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.24	2.55	2.35	1.99	9.81
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	241	295	353	647	671
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	18.5	42.6	64.7	87.1	127
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	68.8	174	211	398	445
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	172	120	142	249	226
Total Liabilities & Shareholders' Equity	241	295	353	647	671
Total Common Shares Outstanding